Targeting the sarcomere to correct muscle function
- PMID: 25881969
- DOI: 10.1038/nrd4554
Targeting the sarcomere to correct muscle function
Abstract
Various human diseases can disrupt the balance between muscle contraction and relaxation. Sarcomeric modulators can be used to readjust this balance either indirectly by intervening in signalling pathways or directly through interaction with the muscle proteins that control contraction. Such agents represent a novel approach to treating any condition in which striated muscle function is compromised, including heart failure, cardiomyopathies, skeletal myopathies and a wide range of neuromuscular conditions. Here, we review agents that modulate the mechanical function of the sarcomere, focusing on emerging compounds that target myosin or the troponin complex.
Similar articles
-
The sarcomeric Z-disc: a nodal point in signalling and disease.J Mol Med (Berl). 2006 Jun;84(6):446-68. doi: 10.1007/s00109-005-0033-1. Epub 2006 Jan 17. J Mol Med (Berl). 2006. PMID: 16416311 Review.
-
Striated muscle cytoarchitecture: an intricate web of form and function.Annu Rev Cell Dev Biol. 2002;18:637-706. doi: 10.1146/annurev.cellbio.18.012502.105840. Epub 2002 Apr 2. Annu Rev Cell Dev Biol. 2002. PMID: 12142273 Review.
-
Inherited disorders of sarcomeric proteins.Curr Opin Neurol. 1999 Oct;12(5):513-8. doi: 10.1097/00019052-199910000-00004. Curr Opin Neurol. 1999. PMID: 10590887 Review.
-
Disuse-induced preferential loss of the giant protein titin depresses muscle performance via abnormal sarcomeric organization.J Gen Physiol. 2008 Jan;131(1):33-41. doi: 10.1085/jgp.200709888. J Gen Physiol. 2008. PMID: 18166625 Free PMC article.
-
p0071, a member of the armadillo multigene family, is a constituent of sarcomeric I-bands in human skeletal muscle.J Muscle Res Cell Motil. 2000;21(6):577-86. doi: 10.1023/a:1026587530656. J Muscle Res Cell Motil. 2000. PMID: 11206135
Cited by
-
UNC-45 assisted myosin folding depends on a conserved FX3HY motif implicated in Freeman Sheldon Syndrome.Nat Commun. 2024 Jul 25;15(1):6272. doi: 10.1038/s41467-024-50442-6. Nat Commun. 2024. PMID: 39054317 Free PMC article.
-
Synthesis and Biophysical Characterization of Fingolimod Derivatives as Cardiac Troponin Antagonists.ACS Med Chem Lett. 2024 Feb 7;15(3):413-417. doi: 10.1021/acsmedchemlett.3c00511. eCollection 2024 Mar 14. ACS Med Chem Lett. 2024. PMID: 38505838 Free PMC article.
-
Advancing clinical translation of cardiac biomechanics models: a comprehensive review, applications and future pathways.Front Phys. 2023 Nov 14;11:1306210. doi: 10.3389/fphy.2023.1306210. Front Phys. 2023. PMID: 38500690 Free PMC article.
-
Cardiac Troponin Activator CK-963 Increases Cardiac Contractility in Rats.J Med Chem. 2024 May 23;67(10):7859-7869. doi: 10.1021/acs.jmedchem.3c02412. Epub 2024 Mar 7. J Med Chem. 2024. PMID: 38451215 Free PMC article.
-
Native Top-Down Mass Spectrometry for Characterizing Sarcomeric Proteins Directly from Cardiac Tissue Lysate.J Am Soc Mass Spectrom. 2024 Apr 3;35(4):738-745. doi: 10.1021/jasms.3c00430. Epub 2024 Feb 29. J Am Soc Mass Spectrom. 2024. PMID: 38422011
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical